Online citations, reference lists, and bibliographies.
← Back to Search

Recent Advances In Nanocarrier-based Mucosal Delivery Of Biomolecules.

Olga Kammona, C. Kiparissides
Published 2012 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
This review highlights the recent developments in the area of nanocarrier-based mucosal delivery of therapeutic biomolecules and antigens. Macromolecular drugs have the unique power to tackle challenging diseases but their structure, physicochemical properties, stability, pharmacodynamics, and pharmacokinetics place stringent demands on the way they are delivered into the body (e.g., inability to cross mucosal surfaces and biological membranes). Carrier-based drug delivery systems can diminish the toxicity of therapeutic biomolecules, improve their bioavailability and make possible their administration via less-invasive routes (e.g., oral, nasal, pulmonary, etc.). Thus, the development of functionalized nanocarriers and nanoparticle-based microcarriers for the delivery of macromolecular drugs is considered an important scientific challenge and at the same time a business breakthrough for the biopharmaceutical industry. In order to be translated to the clinic the nanocarriers need to be biocompatible, biodegradable, stable in biological media, non-toxic and non-immunogenic, to exhibit mucoadhesive properties, to cross mucosal barriers and to protect their sensitive payload and deliver it to its target site in a controlled manner, thus increasing significantly its bioavailability and efficacy.
This paper references
10.1016/J.IJPHARM.2004.10.003
Oral and subcutaneous absorption of insulin poly(isobutylcyanoacrylate) nanoparticles.
M. S. Mesiha (2005)
10.1208/s12249-010-9479-8
The Impact of Vehicles on the Mucoadhesive Properties of Orally Administrated Nanoparticles: a Case Study with Chitosan-4-Thiobutylamidine Conjugate
D. Sakloetsakun (2010)
10.1016/j.ejps.2009.08.010
TMC-MCC (N-trimethyl chitosan-mono-N-carboxymethyl chitosan) nanocomplexes for mucosal delivery of vaccines.
B. Sayin (2009)
10.1016/j.vaccine.2010.11.010
PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration.
Armando Stano (2011)
10.1016/j.vaccine.2008.02.058
Surface modified liposomes for nasal delivery of DNA vaccine.
K. Khatri (2008)
10.1155/2010/589476
Intranasal Immunization with Chitosan/pCAGGS-flaA Nanoparticles Inhibits Campylobacter jejuni in a White Leghorn Model
J. Huang (2010)
10.1016/J.JCONREL.2007.09.013
Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
R. C. Mundargi (2008)
10.1016/j.jconrel.2008.06.005
Depot formulation of vasoactive intestinal peptide by protamine-based biodegradable nanoparticles.
K. Wernig (2008)
10.1186/1472-6750-8-89
Preparation of alginate coated chitosan microparticles for vaccine delivery
X. Li (2008)
10.1016/j.ijpharm.2008.01.008
Solid lipid nanoparticles for pulmonary delivery of insulin.
J. Liu (2008)
10.1021/CR000700M
Peroral route: an opportunity for protein and peptide drug delivery.
A. Sood (2001)
10.1016/j.ijpharm.2011.02.047
Self-double-emulsifying drug delivery system (SDEDDS): a new way for oral delivery of drugs with high solubility and low permeability.
X. Qi (2011)
10.1016/j.ijpharm.2008.06.029
Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
B. Sayin (2008)
10.1016/j.jconrel.2010.11.003
Palatal mucosa as a route for systemic drug delivery: A review.
P. Shakya (2011)
10.1016/J.POLYMER.2007.08.038
Preparation of nanoparticles by the self-organization of polymers consisting of hydrophobic and hydrophilic segments: Potential applications
T. Akagi (2007)
10.1007/s11095-007-9310-8
Preparation and Characterization of Innovative Protein-coated Poly(Methylmethacrylate) Core-shell Nanoparticles for Vaccine Purposes
R. Voltan (2007)
10.1016/j.addr.2008.09.005
Nanoparticles for nasal vaccination.
N. Csaba (2009)
10.1021/IE100307T
Nanocarrier Aided Nasal Vaccination: An Experimental and Computational Approach
Olga Kammona (2011)
10.1016/J.YMTHE.2006.04.010
RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system.
K. Howard (2006)
10.1002/JPS.20718
Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems?
L. Illum (2007)
10.3390/molecules14093754
Nasal Delivery of High Molecular Weight Drugs
Y. Ozsoy (2009)
10.1016/j.ejpb.2008.01.019
Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles.
O. Borges (2008)
10.1016/j.ijpharm.2007.11.027
Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.
Kapil Khatri (2008)
10.1016/J.EJPB.2006.05.005
Nasal immunization studies using liposomes loaded with tetanus toxoid and CpG-ODN.
M. Tafaghodi (2006)
10.1016/j.colsurfb.2010.08.027
Investigation of lectinized liposomes as M-cell targeted carrier-adjuvant for mucosal immunization.
P. Gupta (2011)
10.1007/S11705-009-0291-5
Developing macromolecular therapeutics: the future drug-of-choice
Huining He (2010)
10.1016/j.ijpharm.2009.12.013
PEG-PLA-PEG block copolymeric nanoparticles for oral immunization against hepatitis B.
A. K. Jain (2010)
10.1007/s11095-007-9367-4
Alginate/Chitosan Nanoparticles are Effective for Oral Insulin Delivery
B. Sarmento (2007)
10.1016/j.ejpb.2008.04.015
Liposomal vasoactive intestinal peptide for lung application: protection from proteolytic degradation.
B. Stark (2008)
10.1002/JPS.20750
Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery.
F. Cui (2007)
10.1248/YAKUSHI.128.269
Lipid carriers: a versatile delivery vehicle for proteins and peptides.
M. Rawat (2008)
10.1016/J.LFS.2006.09.040
Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study.
Fang Zheng (2007)
10.1016/J.EJPB.2006.10.009
Nanosized insulin-complexes based on biodegradable amine-modified graft polyesters poly[vinyl-3-(diethylamino)-propylcarbamate-co-(vinyl acetate)-co-(vinyl alcohol)]-graft-poly(L-lactic acid): protection against enzymatic degradation, interaction with Caco-2 cell monolayers, peptide transport and cy
M. Simon (2007)
10.1016/J.BIOMATERIALS.2007.04.023
Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives.
T. Akagi (2007)
10.1016/J.IJPHARM.2006.07.026
Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin.
N. Zhang (2006)
10.1002/JPS.21183
Past, present, and future technologies for oral delivery of therapeutic proteins.
R. Singh (2008)
10.1016/j.jconrel.2008.04.016
Multi-functional nanocarriers for targeted delivery of drugs and genes.
L. Jabr-Milane (2008)
10.1080/10611860500353195
Protective immune responses to meningococcal C conjugate vaccine after intranasal immunization of mice with the LTK63 mutant plus chitosan or trimethyl chitosan chloride as novel delivery platform
B. Baudner (2005)
10.4161/hv.6.9.11561
Recent advances in the development of novel mucosal adjuvants and antigen delivery systems
Wangxue Chen (2010)
10.1016/j.it.2009.04.004
Mucosal immunosenescence: new developments and vaccines to control infectious diseases.
K. Fujihashi (2009)
10.1016/J.JCONREL.2004.07.030
Transmucosal macromolecular drug delivery.
C. Prego (2005)
10.1002/JPS.21082
Engineering biodegradable polyester particles with specific drug targeting and drug release properties.
F. Mohamed (2008)
10.1002/JBM.A.31019
Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles.
S. Hamdy (2007)
10.1007/s11095-006-9087-1
Development of a Novel Method for the Preparation of Thiolated Polyacrylic Acid Nanoparticles
M. Greindl (2006)
10.1016/J.JCONREL.2006.12.023
Helodermin-loaded nanoparticles: characterization and transport across an in vitro model of the follicle-associated epithelium.
A. des Rieux (2007)
10.1016/j.jconrel.2009.02.010
Synthesis, characterization and evaluation of novel triblock copolymer based nanoparticles for vaccine delivery against hepatitis B.
A. K. Jain (2009)
10.1016/J.COLSURFB.2006.09.012
Development and characterization of new insulin containing polysaccharide nanoparticles.
B. Sarmento (2006)
10.1016/j.ijpharm.2008.05.015
Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of protein drugs: III. In vivo oral absorption study.
S. V. R. Rao (2008)
10.1016/j.ejps.2010.12.007
Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
Abdallah Makhlof (2011)
10.1016/j.ejpb.2007.12.001
Effective insulin delivery using starch nanoparticles as a potential trans-nasal mucoadhesive carrier.
A. Jain (2008)
10.1016/J.VACCINE.2007.03.038
Pluronic F127 enhances the effect as an adjuvant of chitosan microspheres in the intranasal delivery of Bordetella bronchiseptica antigens containing dermonecrotoxin.
M. L. Kang (2007)
10.1016/J.IJPHARM.2006.02.031
Preparation and characterization of mucoadhesive polymer-coated nanoparticles.
Fuying Cui (2006)
10.1016/J.IJPHARM.2004.09.002
PLA-PEG particles as nasal protein carriers: the influence of the particle size.
A. Vila (2005)
10.1016/J.VACCINE.2005.12.017
A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice.
A. Joseph (2006)
10.1016/j.coi.2011.03.009
Defending the mucosa: adjuvant and carrier formulations for mucosal immunity.
L. Lawson (2011)
10.1016/J.BBAMEM.2006.11.017
Association of vasoactive intestinal peptide with polymer-grafted liposomes: structural aspects for pulmonary delivery.
B. Stark (2007)
10.1016/J.VACCINE.2005.07.053
Lipid microparticles for mucosal immunization against hepatitis B.
Surbhi Saraf (2006)
10.1016/J.EJPB.2006.09.005
Probing insulin's secondary structure after entrapment into alginate/chitosan nanoparticles.
B. Sarmento (2007)
10.1016/j.jconrel.2009.05.011
Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination.
B. Slütter (2009)
10.1016/j.ijpharm.2009.07.001
Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers.
A. Hafner (2009)
10.1016/j.biomaterials.2009.06.055
Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
Lichen Yin (2009)
10.1016/J.YMETH.2005.11.003
Diphtheria toxoid loaded poly-(ε-caprolactone) nanoparticles as mucosal vaccine delivery systems
J. Singh (2006)
10.1016/J.IJPHARM.2006.02.044
Thiomers: preparation and in vitro evaluation of a mucoadhesive nanoparticulate drug delivery system.
A. Bernkop-Schnürch (2006)
10.1016/j.tibtech.2009.07.009
Therapeutic application of peptides and proteins: parenteral forever?
Zuzana Antošová (2009)
10.1021/BM061131G
Chitosan nanoparticle-loaded mannitol microspheres: structure and surface characterization.
A. Grenha (2007)
10.1016/J.JCONREL.2006.03.017
PLGA:poloxamer and PLGA:poloxamine blend nanostructures as carriers for nasal gene delivery.
N. Csaba (2006)
10.1080/10611860701637966
Rational design of nasal vaccines
B. Slütter (2008)
10.1016/J.BIOMATERIALS.2006.02.026
Novel delivery system based on complexation hydrogels as delivery vehicles for insulin-transferrin conjugates.
Nikhil J. Kavimandan (2006)
10.1002/jps.21493
Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems.
S. Sharma (2009)
10.1016/J.IJPHARM.2004.12.030
New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin.
M. Garcia-Fuentes (2005)
10.1023/B:PHAM.0000022414.17183.58
Novel Chitosan Particles and Chitosan-Coated Emulsions Inducing Immune Response via Intranasal Vaccine Delivery
Takahiro Nagamoto (2004)
10.1016/S0939-6411(03)00147-4
Review articleThiolated chitosans
A. Bernkop-Schnürch (2004)
10.1016/J.EJPB.2003.09.006
Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.
A. Vila (2004)
10.1016/j.jconrel.2009.01.011
Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
M. Rekha (2009)
10.1016/j.ijpharm.2009.11.026
Preparation and evaluation of self-nanoemulsified drug delivery systems (SNEDDSs) of matrine based on drug-phospholipid complex technique.
J. Ruan (2010)
10.1016/J.IJPHARM.2006.03.047
Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN.
M. Tafaghodi (2006)
10.1016/j.vaccine.2008.12.004
New approach on the development of a mucosal vaccine against strangles: Systemic and mucosal immune responses in a mouse model.
H. Florindo (2009)
10.2147/IJN.S4937
Nanomedicine in pulmonary delivery
H. M. Mansour (2009)
10.1038/nm1213
Mucosal immunity and vaccines
J. Holmgren (2005)
10.4049/jimmunol.0802928
Targeted Delivery of Immunogen to Primate M Cells with Tetragalloyl Lysine Dendrimer1
S. Misumi (2009)
10.1016/j.vaccine.2011.04.112
Pharmaceutical and immunological evaluation of mucoadhesive nanoparticles based delivery system(s) administered intranasally.
S. Mangal (2011)
10.1016/J.EJPB.2006.01.010
In vivo induction of mucosal immune responses by intranasal administration of chitosan microspheres containing Bordetella bronchiseptica DNT.
M. L. Kang (2006)
10.1007/s11095-008-9657-5
Evaluation of Bioadhesive Capacity and Immunoadjuvant Properties of Vitamin B12-Gantrez Nanoparticles
Hesham H. Salman (2008)
10.1016/J.JCONREL.2006.05.013
Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation.
F. Cui (2006)
10.1016/J.JCONREL.2006.10.023
Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats.
C. Damgé (2007)
10.1016/J.JCONREL.2007.06.024
Lectin-conjugated PLGA nanoparticles loaded with thymopentin: ex vivo bioadhesion and in vivo biodistribution.
Yashu Yin (2007)
10.1016/J.IJPHARM.2007.03.025
Intranasal delivery: physicochemical and therapeutic aspects.
H. Costantino (2007)
10.1016/J.IJPHARM.2007.07.035
In vitro and in vivo study of N-trimethyl chitosan nanoparticles for oral protein delivery.
Fu Chen (2008)
10.1080/02652040801903843
Improved bioavailability of orally delivered insulin using Eudragit-L30D coated PLGA microparticles
Pratap C. Naha (2008)
10.1016/j.biomaterials.2008.10.035
The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-epsilon-caprolactone-based nanoparticles.
H. Florindo (2009)
10.1096/fj.09-129825
Surface‐functionalized nanoparticles for targeted gene delivery across nasal respiratory epithelium
Sneha Sundaram (2009)
10.1016/j.jconrel.2010.02.001
A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Abdallah Makhlof (2011)
10.1016/J.JCONREL.2006.09.015
Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin.
Yashu Yin (2006)
10.1021/bm800975j
New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules.
D. Teijeiro-Osorio (2009)
10.1016/j.addr.2009.11.012
Nanotechnology solutions for mucosal immunization.
S. Chadwick (2010)
10.1211/jpp.58.3.0003
Chitosan nanoparticles encapsulated vesicular systems for oral immunization: preparation, in‐vitro and in‐vivo characterization
S. Jain (2006)
10.1016/j.ijpharm.2008.05.018
Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: I. Formulation development.
S. V. R. Rao (2008)
10.1016/J.JCONREL.2007.04.021
PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination.
M. Garinot (2007)
10.1016/J.EJPB.2007.05.007
Preparation and physicochemical characterization of supercritically dried insulin-loaded microparticles for pulmonary delivery.
M. Amidi (2008)
10.1016/j.biomaterials.2007.12.025
The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization.
H. Jiang (2008)
10.1080/10717540701606467
Novel Approach for Delivery of Insulin Loaded Poly(lactide-co-glycolide) Nanoparticles Using a Combination of Stabilizers
P. S. Kumar (2007)
10.1016/J.ADDR.2005.07.002
Thiomers: a new generation of mucoadhesive polymers.
A. Bernkop-Schnürch (2005)
10.1016/j.ejps.2009.12.004
Preparation and in vitro-in vivo evaluation of Witepsol H35 based self-nanoemulsifying drug delivery systems (SNEDDS) of coenzyme Q(10).
Pushp R Nepal (2010)
10.1007/s00795-006-0335-6
Uptake of microparticles into the epithelium of human nasopharyngeal lymphoid tissue
Y. Fujimura (2006)
10.1016/J.IJPHARM.2007.03.005
Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system.
A. Krauland (2007)
10.1016/J.JCONREL.2006.06.011
Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination.
O. Borges (2006)
10.1016/J.ADDR.2005.07.009
Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives.
M. I. Ugwoke (2005)
10.1208/aapsj070104
Carrier-based strategies for targeting protein and peptide drugs to the lungs
Sally-Ann Cryan (2008)
10.1016/0169-409X(95)00113-L
Mechanisms of macromolecule absorption by the lungs
John S. Patton (1996)
10.1016/J.IJPHARM.2006.08.040
Distribution, transition, adhesion and release of insulin loaded nanoparticles in the gut of rats.
Ming-guang Li (2007)
10.1016/j.ijpharm.2011.01.060
Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa.
S. Dünnhaupt (2011)
10.1016/j.biomaterials.2011.02.011
In vivo evidence of oral vaccination with PLGA nanoparticles containing the immunostimulant monophosphoryl lipid A.
Federica Sarti (2011)
10.1080/03639040802235894
Optimized Formulation of High-Payload PLGA Nanoparticles Containing Insulin–Lauryl Sulfate Complex
K. Shi (2009)
10.1016/J.JBIOTEC.2007.02.007
Preparation, characterization and transfection efficiency of cationic PEGylated PLA nanoparticles as gene delivery systems.
J. Chen (2007)
10.1016/J.JCONREL.2005.11.014
Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system.
M. Amidi (2006)
10.1016/J.IJPHARM.2006.06.019
Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery.
S. Sajeesh (2006)
10.1007/s10529-006-9086-7
Protective immunity in rats by intranasal immunization with Streptococcus mutans glucan-binding protein D encapsulated into chitosan-coated poly(lactic-co-glycolic acid) microspheres
H. Zhao (2006)
10.1586/14760584.4.2.185
Nanoparticles as carriers for nasal vaccine delivery
M. Köping-Höggård (2005)
10.1016/j.biomaterials.2011.08.087
A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery.
M. Chen (2011)
10.1002/jbm.b.31161
Chitosan-NAC nanoparticles as a vehicle for nasal absorption enhancement of insulin.
X. Wang (2009)
10.1016/j.biomaterials.2010.09.034
Oral nuclear factor-κB decoy oligonucleotides delivery system with chitosan modified poly(D,L-lactide-co-glycolide) nanospheres for inflammatory bowel disease.
Kohei Tahara (2011)
10.1016/J.JCONREL.2006.08.013
Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.
A. des Rieux (2006)
10.1046/J.1365-2125.2003.01892.X
Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications.
N. Labiris (2003)
10.1016/j.ijpharm.2008.05.016
Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: II. In vitro transport study.
S. V. R. Rao (2008)
10.1016/J.EJPB.2006.11.028
Chitosan microspheres enhance the immunogenicity of an Ag85B-based fusion protein containing multiple T-cell epitopes of Mycobacterium tuberculosis.
B. Zhu (2007)
10.1016/J.VACCINE.2006.06.086
N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model.
M. Amidi (2007)
10.1021/BM0703923
Oral bioavailability of insulin contained in polysaccharide nanoparticles.
B. Sarmento (2007)
10.1016/S0169-409X(01)00169-7
Manipulating the immune system: humoral versus cell-mediated immunity.
E. McNeela (2001)
10.1163/156856208X393464
Molecular Aspects of Mucoadhesive Carrier Development for Drug Delivery and Improved Absorption
N. Peppas (2009)
10.1016/J.IJPHARM.2006.03.017
Lectin anchored stabilized biodegradable nanoparticles for oral immunization 1. Development and in vitro evaluation.
P. Gupta (2006)
10.1016/j.ijpharm.2008.03.036
Induction of high antitoxin titers against tetanus toxoid in rabbits by intranasal immunization with dextran microspheres.
S. A. Sajadi Tabassi (2008)
10.1016/j.ijpharm.2008.01.046
Inhalable liposomal formulation for vasoactive intestinal peptide.
Franz Hajos (2008)
10.1016/j.ejpb.2008.09.022
Engineering design and molecular dynamics of mucoadhesive drug delivery systems as targeting agents.
Laura Serra (2009)
10.1021/bm9001377
Chitosan-alginate blended nanoparticles as carriers for the transmucosal delivery of macromolecules.
F. M. Goycoolea (2009)
10.1016/J.VACCINE.2005.12.016
Protection against bubonic and pneumonic plague with a single dose microencapsulated sub-unit vaccine.
S. J. Elvin (2006)
10.1016/j.ejpb.2007.10.017
Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins.
A. Grenha (2008)
10.1517/17425247.1.1.141
Particle uptake by Peyer’s patches: a pathway for drug and vaccine delivery
Monjed Shakweh (2004)
10.1016/j.jconrel.2009.07.017
Nanocomposites of lung surfactant and biodegradable cationic nanoparticles improve transfection efficiency to lung cells.
J. Nguyen (2009)
10.1002/PSSC.200780129
Nanotechnology advances in controlled drug delivery systems
C. Kiparissides (2008)
10.1016/J.VACCINE.2006.01.011
Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally.
K. S. Jaganathan (2006)



This paper is referenced by
10.1007/s11095-014-1612-z
Semi-Automated Nanoprecipitation-System—An Option for Operator Independent, Scalable and Size Adjustable Nanoparticle Synthesis
R. Rietscher (2014)
10.1080/10717544.2019.1568622
A thermosensitive gel based on w1/o/w2 multiple microemulsions for the vaginal delivery of small nucleic acid
J. Wang (2019)
10.1016/j.nano.2014.09.019
Liposome-based mucus-penetrating particles (MPP) for mucosal theranostics: demonstration of diamagnetic chemical exchange saturation transfer (diaCEST) magnetic resonance imaging (MRI).
T. Yu (2015)
10.1080/1061186X.2017.1326123
The application of polysaccharide-based nanogels in peptides/proteins and anticancer drugs delivery
Lin Zhang (2017)
10.1021/nl502994y
A Solvent-Free Thermosponge Nanoparticle Platform for Efficient Delivery of Labile Proteins
W. I. Choi (2014)
Hepatitis B core antigen virus-like particles : characterization and investigation 1 of their stability in simulated and pig gastro-intestinal fluids 2 3
A. Berardi (2018)
10.1016/j.jtcms.2017.07.007
Identification and molecular cloning of novel antimicrobial peptides from skin secretions of Odorrana versabilis and Rana palustris
Y. Wu (2017)
10.1016/J.NANTOD.2014.06.003
Nanomedicine in the Management of Microbial Infection - Overview and Perspectives.
Xi Zhu (2014)
10.1016/B978-0-323-41532-3.00013-0
Engineered nanoparticles as a precise delivery system in cancer therapeutics
R. Sharma (2016)
10.1002/adhm.201800670
Self-Assembled Nanomedicines for Anticancer and Antibacterial Applications.
Lingyun Zhou (2018)
10.1142/S179398441441013X
Enzyme-Functionalized PLGA Nanoparticles with Enhanced Mucus Permeation Rate
E. Samaridou (2014)
10.1002/9781119640240.ch11
Vaginal Bioadhesive Drug Delivery Systems and Their Applications
Anju Sharma (2020)
10.1016/j.biomaterials.2013.11.073
Targeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosan.
Tao Jiang (2014)
10.14710/JKSA.21.2.92-97
Synthesis of Nano Chitosan as Carrier Material of Cinnamon’s Active Component
Ngadiwiyana Ngadiwiyana (2018)
10.1016/j.ijpharm.2016.11.055
Nasal drug delivery: Design of a novel mucoadhesive and in situ gelling polymer.
Claudia Menzel (2017)
10.1016/j.ejpb.2018.05.009
Recent advances in carrier mediated nose‐to‐brain delivery of pharmaceutics
V. Bourganis (2018)
10.1016/j.jddst.2019.101286
Polycaprolactone based nano-carrier for co-administration of moxifloxacin and rutin and its In-vitro evaluation for sepsis
Mayank Handa (2019)
STOMACH-SPECIFIC MUCOADHESIVE NANOPARTICLES AS A CONTROLLED RELEASE DRUG DELIVERY SYSTEM
Aanand Ankit Kharia (2013)
10.4161/hv.23137
Synergistic effect of methionine encephalin (MENK) combined with pidotimod(PTD) on the maturation of murine dendritic cells (DCs)
Y. Meng (2013)
10.1081/e-ebpp-120049274
Biodegradable Polymers: Protein Therapeutics Delivery
Bhuvaneshwar Vaidya (2015)
10.1016/j.biotechadv.2014.12.004
Polymer nanotechnology based approaches in mucosal vaccine delivery: challenges and opportunities.
R. Sharma (2015)
10.1093/mmy/myx155
Development, characterization, and in vitro‐in vivo evaluation of polymeric nanoparticles containing miconazole and farnesol for treatment of vulvovaginal candidiasis
Adelaide Fernandes Costa (2019)
10.3389/fbioe.2020.558349
Chitosan Nanoparticle Based Mucosal Vaccines Delivered Against Infectious Diseases of Poultry and Pigs
S. Renu (2020)
10.1002/9780470571224.PSE558
ADME Processes in Vaccines and PK/PD Approaches for Vaccination Optimization
José David Gómez-Mantilla (2015)
10.1007/s11259-015-9645-2
Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization
M. Abkar (2015)
10.1016/B978-0-323-46143-6.00017-8
Nanoparticulate carrier(s): an emerging paradigm in new generation vaccine development
R. Sharma (2017)
10.1007/s40136-012-0003-4
Topical Drug Delivery for Chronic Rhinosinusitis
J. Liang (2012)
10.1016/j.vaccine.2015.07.101
Chitosan-based mucosal adjuvants: Sunrise on the ocean
Y. Xia (2015)
10.1002/adhm.201600599
Mucus-Penetrating Nanosuspensions for Enhanced Delivery of Poorly Soluble Drugs to Mucosal Surfaces.
T. Yu (2016)
10.1016/j.ejps.2019.105099
Nanoemulsions and thermosensitive nanoemulgels of phenytoin and fosphenytoin for intranasal administration: formulation development and in vitro characterization.
Patrícia C Pires (2019)
10.21776/ub.industria.2019.008.03.1
Formulasi Nanoemulsi Ekstrak Daun Kelor (Moringa oleifera Lamk)
Nina Jusnita (2019)
10.1016/j.addr.2016.02.011
Oral delivery of diabetes peptides - Comparing standard formulations incorporating functional excipients and nanotechnologies in the translational context.
H. R. Lakkireddy (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar